Identiv Inc (INVE) Stock News

Rosen Law Firm has filed securities class action lawsuits against Graphic Packaging Holding Company, Sportradar Group AG, and FS KKR Capital Corp., alleging that defendants made false or misleading statements regarding their financial performance and business conditions. Investors with losses exceeding $100,000 are encouraged to join the class actions before the July 6, 2026 lead plaintiff deadline.

Rosen Law Firm has issued multiple securities class action deadline alerts for investors. The primary case involves Sportradar Group AG (SRAD), where investors who purchased shares between November 7, 2024 and April 21, 2026 may be entitled to compensation. The lawsuit alleges that Sportradar made false statements about compliance and worked with black-market gambling operators while claiming strict regulatory adherence. The lead plaintiff deadline is July 17, 2026. Similar deadline alerts were also issued for FS KKR Capital Corp. (FSK) and Regencell Bioscience Holdings Limited (RGC).

Via Transportation, Inc. faces a class action lawsuit alleging its September 2025 IPO offering documents were materially false and misleading. The company allegedly concealed declining revenue per customer and regulatory issues in Germany. Stock has dropped approximately 70% below the IPO price of $46 following successive negative earnings announcements. Investors with substantial losses have until August 10, 2026 to seek lead plaintiff status.

Law firm Bronstein, Gewirtz & Grossman, LLC announced an investigation into Gildan Activewear Inc. following a Jehoshaphat Research report alleging channel stuffing, revenue manipulation, and off-balance-sheet financial engineering. The allegations caused Gildan's stock to fall 18.8% on June 16, 2026. The firm is seeking investors who purchased Gildan securities to participate in the investigation.

Rosen Law Firm is reminding investors in Regencell Bioscience Holdings Limited (RGC) and AeroVironment, Inc. (AVAV) of upcoming lead plaintiff deadlines in securities class action lawsuits. The lawsuits allege that defendants made false or misleading statements regarding market manipulation vulnerabilities, regulatory risks, and financial exposure during their respective class periods.

Rosen Law Firm has filed a class action lawsuit against BitGo Holdings, Inc. on behalf of investors who purchased securities during the company's January 2026 IPO and through May 13, 2026. The lawsuit alleges that BitGo's offering documents contained materially false and misleading statements, specifically understating risks related to declining digital asset prices and their impact on the company's business and financial performance. Investors must move the court by August 7, 2026 to serve as lead plaintiff.

Rosen Law Firm has filed a securities class action lawsuit against POET Technologies Inc. for allegedly making false and misleading statements regarding its tax status as a potential passive foreign investment company (PFIC), failing to disclose negative tax implications for U.S. stockholders, and an executive's violation of a non-disclosure agreement. Investors with losses exceeding $100,000 are encouraged to join the class action before the June 29, 2026 deadline.

Rosen Law Firm has filed a class action lawsuit against Nano-X Imaging Ltd. (NNOX) on behalf of investors who purchased securities between March 31, 2025 and April 17, 2026. The lawsuit alleges that defendants made false and misleading statements regarding operational efficiency gains and product demand, while concealing poor alignment between production and demand, increased operating expenses, and significant cash burn that necessitated restructuring measures.

Pomerantz LLP is investigating Biogen Inc. for potential securities fraud following the company's announcement of Phase 2 CELIA study results for diranersen (BIIB080), an Alzheimer's disease treatment. Although Biogen described the results as 'compelling,' the study missed its primary dose-response endpoint, causing the stock to fall $13.16 per share (6.43%) to $191.37 on May 14, 2026.

BP's board unanimously removed Chair and Director Albert Manifold on May 26, 2026, citing serious governance, oversight, and conduct concerns. The announcement triggered a 3.85% decline in BP's American Depositary Share price, falling $1.71 to $42.65. Pomerantz LLP is investigating potential securities fraud and unlawful business practices.

Pomerantz LLP is investigating AECOM for potential securities fraud following the company's disclosure of significantly delayed claim resolutions on projects from 2019-2020. AECOM reported a 98% decline in quarterly operating cash flow to $4 million and negative adjusted free cash flow of $27 million in Q2 fiscal 2026. The company's claims recorded in contract assets surged from $400 million to $680 million, leading to a 12% stock price decline of $9.55 per share on May 12, 2026.

Pomerantz LLP is investigating The Ensign Group for potential securities fraud following a Hunterbrook short report alleging inadequate patient care, understaffing, and misuse of taxpayer funds. The allegations claim patients have suffered and died as a result of the company's practices. Ensign Group's stock fell 8.15% ($13.88 per share) to $156.42 on June 8, 2026, following the report's publication.

Pomerantz LLP is investigating potential securities fraud at Aether Holdings (ATHR), following a July 2025 short report by BMF Reports alleging fake filings, insider enrichment, lock-up violations, and undisclosed dealings. The allegations included concerns about a subsidiary acquisition with minimal business fundamentals. Aether's stock fell 23.95% on the report's publication.

Pomerantz LLP is investigating potential securities fraud claims against Portillo's Inc. following significant downward guidance revisions announced in September 2025. The company reduced fiscal 2025 revenue and EBITDA growth targets, cut unit-growth expectations from 12 to 8 restaurants, and lowered same-restaurant sales outlook from 1-3% growth to 1-1.5% decline. The stock fell 5.67% on the announcement.

Pomerantz LLP is investigating potential securities fraud claims against Medline Industries following an FDA warning letter on June 2, 2026, citing significant violations of Good Manufacturing Practice regulations for pharmaceuticals. The announcement triggered a 7.16% stock price decline ($2.56 per share) for Medline.

Pomerantz Law Firm has filed a class action lawsuit against Fitness Champs Holdings Ltd. (FCHL) alleging securities fraud and market manipulation. The complaint claims FCHL was used in a 'pump-and-dump' scheme where impersonators posed as financial advisors to artificially inflate the stock price to $7.20 on September 19, 2025, before it collapsed 84.6% to $1.07 on September 23, 2025. Investors who purchased FCHL securities during the class period are urged to contact the firm by the June 16, 2026 deadline.

Rosen Law Firm has filed a class action lawsuit against Erasca, Inc. on behalf of investors who purchased common stock between January 14, 2025 and April 26, 2026. The lawsuit alleges that Erasca and its executives made false and misleading statements about its lead oncology drug candidate ERAS-0015, including improper comparisons to a competing drug and undisclosed patent disputes. Investors who wish to serve as lead plaintiff must file by August 10, 2026.

Rosen Law Firm is soliciting investors who purchased Sportradar Group AG shares between November 7, 2024 and April 21, 2026 to join a securities class action lawsuit. The lawsuit alleges that Sportradar made false statements about compliance and ethics while secretly working with black-market gambling operators and maintaining inadequate Know-Your-Customer processes. The lead plaintiff deadline is July 17, 2026.

Comstock Resources sold a 27% non-controlling equity interest in its midstream subsidiary Pinnacle Gas Services to Sixth Street for $600 million, valuing Pinnacle at $2.2 billion enterprise value. Comstock retained 73% controlling interest and used proceeds to eliminate all Pinnacle debt and preferred equity while reducing annual fixed charges by approximately $40 million. The transaction strengthens Comstock's balance sheet and validates the value of its Western Haynesville acreage.

Rosen Law Firm has filed a class action lawsuit against Via Transportation, Inc. (NYSE: VIA) on behalf of IPO investors, alleging that the company's offering documents were false and misleading. The complaint claims Via omitted material facts about declining Platform Annual Run-Rate Revenue and inability to grow in Germany. Via's stock has declined approximately 70% from its IPO price to $14.52. The deadline to serve as lead plaintiff is August 10, 2026.

Rosen Law Firm is encouraging investors who purchased Zoetis Inc. securities between January 14, 2025 and May 6, 2026 to join a class action lawsuit. The lawsuit alleges that Zoetis made false statements about market share and sales growth while failing to disclose weakening adoption of key products like Librela due to FDA safety warnings, market share losses in Simparica Trio and dermatology products, and declining veterinarian adoption. The lead plaintiff deadline is July 27, 2026.

Rosen Law Firm is urging investors who purchased Veritone, Inc. securities between October 14, 2025 and April 14, 2026 to join a class action lawsuit before the July 20, 2026 lead plaintiff deadline. The lawsuit alleges that Veritone made false statements about its financial performance, inaccurately recorded revenue and costs, overstated assets, and maintained deficient internal controls, leading to required financial statement restatements.

Rosen Law Firm is notifying investors in Phreesia, Inc., Babcock & Wilcox Enterprises, Inc., and TruBridge, Inc. of ongoing securities class action lawsuits. Phreesia investors have until July 13, 2026 to serve as lead plaintiff. The lawsuit alleges Phreesia made false statements about slowing demand and reduced visibility in key revenue streams, particularly in its Network Solutions segment.

A securities class action lawsuit has been filed against Babcock & Wilcox Enterprises, Inc. for allegedly making false and misleading statements regarding a Power Generation contract with Applied Digital. The lawsuit claims that B&W's largest shareholder BRC Group Holdings stood on both sides of the contract and that Applied Digital did not actually need the products/services, raising questions about revenue recognition and overstating business prospects. Investors who purchased B&W securities between November 5, 2025 and March 11, 2026 may be eligible for compensation.

Securities law firm Faruqi & Faruqi is investigating Zscaler for potentially misleading investors about growth outlook, sales execution, and customer expansion. The company issued weaker-than-expected guidance on May 27, 2026, citing sales leadership disruptions, causing the stock to plunge 31.52% in a single day—its steepest decline since going public. The firm is seeking eligible investors who suffered losses to participate in potential litigation.

A class action lawsuit has been filed against Microsoft Corporation alleging that executives made false and misleading statements regarding Copilot product issues, underperformance versus competitors, and undisclosed capital expenditure increases. The lawsuit covers the period from May 1, 2025 to January 28, 2026. Microsoft's stock fell nearly 10% following disappointing earnings results that revealed Azure growth slowdown due to GPU/CPU diversion to AI projects, only 15 million paid Copilot seats versus analyst expectations, and capital expenditures of $37.5 billion in Q2 fiscal 2026.

Rosen Law Firm is urging investors who purchased Graphic Packaging Holding Company (GPK) securities between February 4, 2025 and February 2, 2026 to join a class action lawsuit. The lawsuit alleges that the company made false statements regarding inventory management issues, reduced demand, increased costs, and overstated its business model strength. Investors must act by the July 6, 2026 lead plaintiff deadline.

Rosen Law Firm has filed a class action lawsuit against Helen of Troy Limited on behalf of investors who purchased common stock between April 24, 2024 and October 8, 2025. The lawsuit alleges misrepresentations regarding Project Pegasus, a restructuring program, where the company assured investors of progress despite acknowledged implementation issues with its Tennessee distribution center. The lead plaintiff deadline is August 3, 2026.

Law firm Bragar Eagel & Squire is investigating Kemper Corporation for potential federal securities law violations following the company's May 6, 2026 disclosure about increased minimum liability limits and elevated loss costs in California. The announcement triggered a 10% stock price decline from $32.77 to $29.40 per share. The firm is seeking stockholders who suffered losses to participate in the action.

Rosen Law Firm has filed class action lawsuits against Verra Mobility Corporation, Erasca, Inc., and FS KKR Capital Corp. on behalf of investors who suffered losses. The Verra Mobility lawsuit alleges the company made false statements regarding its relationship with Avis Budget Group and concealed material adverse facts. Investors have until August 4, 2026 to move the court to serve as lead plaintiff.